Fresenius Kabi USA, LLC — FDA Class III (D-0581-2026)

Fresenius Kabi USA, LLC is recalling 898,050 vials of a human prescription drug due to failed impurities and degradation specifications. This recall is classified as a voluntary action. The affected products are administered via intramuscular and intraocular routes.

• •Fresenius Kabi USA, LLC is recalling 898,050 vials of a drug.
• •The recall is due to failed impurity specifications.
• •The affected products are for intramuscular and intraocular use.
• •Patients should check their medicine cabinets for these vials.

Patients who have received this drug should check for the recalled vials due to contamination risks. The recall involves 898,050 vials, which could pose safety concerns.